Immobilized Human PVRIG Protein, hFc Tag at 2 μg/mL (100 μL/well) can bind Recombinant Human Nectin-2/PVRL2/CD112 Protein with EC50 of 9-45 ng/ml.
Product Details
Product Details
Product Specification
| Species | Human |
| Synonyms | Transmembrane protein PVRIG, CD112 receptor (CD112R), Poliovirus receptor-related immunoglobulin domain-containing protein, PVRIG, C7orf15 |
| Accession | Q6DKI7 |
| Amino Acid Sequence | Protein sequence (Q6DKI7, Thr41-Asp171, with C-hFc tag) TPEVWVQVRMEATELSSFTIRCGFLGSGSISLVTVSWGGPNGAGGTTLAVLHPERGIRQWAPARQARWETQSSISLILEGSGASSPCANTTFCCKFASFPEGSWEACGSLPPSSDPGLSAPPTPAPILRAD |
| Expression System | HEK293 |
| Molecular Weight | Predicted MW: 39.7 kDaObserved MW: 54 kDa |
| Purity | >95% by SDS-PAGE |
| Endotoxin | <1EU/μg |
| Conjugation | Unconjugated |
| Tag | with C-hFc Tag |
| Physical Appearance | Lyophilized powder |
| Storage Buffer | Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4 with 3% trehalose. |
| Reconstitution | Reconstitute no more than 1 mg/mL according to the size in deionized water after rapid centrifugation. |
| Stability & Storage | 12 months from date of receipt, -20 to -70 °C as supplied. |
Background
PVRIG (also known as CD112R) is an immune checkpoint protein belonging to the DNAM-1/TIGIT/CD96 family. It interacts with its ligand, PVRL2 (CD112), which is expressed on antigen-presenting cells and tumor cells. PVRIG functions as a co-inhibitory receptor, primarily expressed on T cells and NK cells, and plays a critical role in modulating immune responses. By binding to PVRL2, PVRIG suppresses T-cell and NK-cell activation, contributing to immune evasion in cancers.
Picture
Picture
Bioactivity
SDS-PAGE
2μg(R: reducing conditions)
